684 related articles for article (PubMed ID: 7961551)
1. Motor and mental side effects of clozapine.
Gerlach J; Peacock L
J Clin Psychiatry; 1994 Sep; 55 Suppl B():107-9. PubMed ID: 7961551
[TBL] [Abstract][Full Text] [Related]
2. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of akathisia in patients receiving stable doses of clozapine.
Chengappa KN; Shelton MD; Baker RW; Schooler NR; Baird J; Delaney J
J Clin Psychiatry; 1994 Apr; 55(4):142-5. PubMed ID: 7915271
[TBL] [Abstract][Full Text] [Related]
4. Assessment of EPS and tardive dyskinesia in clinical trials. Collaborative Working Group on Clinical Trial Evaluations.
J Clin Psychiatry; 1998; 59 Suppl 12():23-7. PubMed ID: 9766616
[TBL] [Abstract][Full Text] [Related]
5. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?
Levin H; Chengappa KN; Kambhampati RK; Mahdavi N; Ganguli R
J Clin Psychiatry; 1992 Jul; 53(7):248-51. PubMed ID: 1353492
[TBL] [Abstract][Full Text] [Related]
6. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
Li CR; Chung YC; Park TW; Yang JC; Kim KW; Lee KH; Hwang IK
World J Biol Psychiatry; 2009; 10(4 Pt 3):919-24. PubMed ID: 19995222
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic treatment of schizophrenia.
Levinson DF
Clin Ther; 1991; 13(3):326-52. PubMed ID: 1683269
[TBL] [Abstract][Full Text] [Related]
8. Movement disorders associated with neuroleptic treatment.
Wirshing WC
J Clin Psychiatry; 2001; 62 Suppl 21():15-8. PubMed ID: 11584982
[TBL] [Abstract][Full Text] [Related]
9. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia.
Andrew HG
Can J Psychiatry; 1994 Nov; 39(9 Suppl 2):S76-80. PubMed ID: 7874668
[TBL] [Abstract][Full Text] [Related]
10. Extrapyramidal symptoms during long-term treatment with antipsychotics: special focus on clozapine and D1 and D2 dopamine antagonists.
Gerlach J; Lublin H; Peacock L
Neuropsychopharmacology; 1996 Mar; 14(3 Suppl):35S-39S. PubMed ID: 8866742
[TBL] [Abstract][Full Text] [Related]
11. Does clozapine cause tardive dyskinesia?
Kane JM; Woerner MG; Pollack S; Safferman AZ; Lieberman JA
J Clin Psychiatry; 1993 Sep; 54(9):327-30. PubMed ID: 8104929
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis.
Small JG; Milstein V; Marhenke JD; Hall DD; Kellams JJ
J Clin Psychiatry; 1987 Jul; 48(7):263-7. PubMed ID: 2885310
[TBL] [Abstract][Full Text] [Related]
13. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
Ganzini L; Casey DE; Hoffman WF; McCall AL
Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
[TBL] [Abstract][Full Text] [Related]
14. Clozapine, negative symptoms, and extrapyramidal side effects.
Kane JM; Safferman AZ; Pollack S; Johns C; Szymanski S; Kronig M; Lieberman JA
J Clin Psychiatry; 1994 Sep; 55 Suppl B():74-7. PubMed ID: 7961579
[TBL] [Abstract][Full Text] [Related]
15. Clozapine-induced tardive dyskinesia: a case report.
Ertugrul A; Demir B
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):633-5. PubMed ID: 15866369
[TBL] [Abstract][Full Text] [Related]
16. Evolution of neuroleptic-induced extrapyramidal syndromes under long-term neuroleptic treatment.
Modestin J; Wehrli MV; Stephan PL; Agarwalla P
Schizophr Res; 2008 Mar; 100(1-3):97-107. PubMed ID: 18055180
[TBL] [Abstract][Full Text] [Related]
17. Adverse effects of antipsychotic drugs.
Malhotra AK; Litman RE; Pickar D
Drug Saf; 1993 Dec; 9(6):429-36. PubMed ID: 7907481
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of tardive dystonia, tardive dyskinesia, parkinsonism and akathisia The Curaçao Extrapyramidal Syndromes Study: I.
van Harten PN; Matroos GE; Hoek HW; Kahn RS
Schizophr Res; 1996 May; 19(2-3):195-203. PubMed ID: 8789918
[TBL] [Abstract][Full Text] [Related]
19. Depot neuroleptics: side effects and safety.
Marder SR
J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):24S-29S. PubMed ID: 2870089
[TBL] [Abstract][Full Text] [Related]
20. Antipsychotic-induced movement disorders - forgotten but not gone.
Weiden PJ
Acta Psychiatr Scand; 2008 Jun; 117(6):401-2. PubMed ID: 18479315
[No Abstract] [Full Text] [Related]
[Next] [New Search]
